Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3546 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Bayer suspends sales of Trasylol

The company took this global action following direction from the German BfArM and requests from the FDA and other regulators that Bayer temporarily suspend Trasylol marketing in their

Genoptix closes IPO

The purchase price of the shares was $17 per share. Genoptix sold a total of 4,735,714 shares in the offering, resulting in net proceeds of approximately $72.7 million

Immtech concludes malaria prevention trial

The exploratory study was designed to determine whether the company should focus on commercializing a blood-stage or a liver-stage malaria prevention drug. Participants in the randomized placebo controlled